Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes

Tolvaptan is a selective V(2)-receptor antagonist primarily metabolized by CYP 3A. The present study investigated the hepatocellular disposition of tolvaptan and the generated tolvaptan metabolites, DM-4103 and DM-4107, as well as the potential for drug-drug interactions (DDIs) with metabolic and tr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Metab Dispos
Hlavní autoři: Lu, Yang, Slizgi, Jason R., Brouwer, Kenneth R., St. Claire, Robert L., Freeman, Kimberly M., Pan, Maxwell, Brock, William J., Brouwer, Kim L. R.
Médium: Artigo
Jazyk:Inglês
Vydáno: The American Society for Pharmacology and Experimental Therapeutics 2016
Témata:
Short Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885486/
https://ncbi.nlm.nih.gov/pubmed/27013400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.115.067629
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky